Ik-Kyung (IK) Jang, MD, PhD
Director, Clinical Trials Program
- Phone: 617-726-9226
- Departments
- Cardiology
- Department of Medicine
Specialties
- Critical Care Center
- Cardiac Intensive Care Unit
- Heart Center
- Interventional Cardiology
- Coronary Artery Disease Program
- Clinical Interests
- Acute coronary syndromes
- Interventional cardiology
- Acute heart attack
- Intravascular Imaging
- Optical coherence tomography (OCT)
- Locations
- Boston: Massachusetts General Hospital
- Medical Education
- MD, Kyung Hee University
- Residency, University Hospitals of Leuven
- Fellowship, Massachusetts General Hospital
- Fellowship, University Hospitals of Leuven
- Board Certifications
- Cardiovascular Disease, American Board of Internal Medicine
- Interventional Cardiology, American Board of Internal Medicine
- Gender
- Male
- Foreign Languages
- Dutch
- Korean
- Patient Age Group
- Adult
- Accepting New Patients
- Yes
BiographyDr. Jang came to Massachusetts General Hospital in 1987 from Leuven University in Belgium, where he has completed his residency in medicine and fellowship in cardiology. He also successfully defended his doctorate thesis at the same university. After his advanced fellowship in cardiology at MGH, he joined the staff and is currently working as a Physician and an interventional cardiologist in the Cardiology Division. He holds currently an academic title of Professor of Medicine at Harvard Medical School.
A recipient of the Partners in Excellence Award for Research in 2000 and for leadership in 2006, his research roster is extensive, and is focused on acute coronary syndromes including acute myocardial infarction. His earlier research focused on pharmacology and physiology of thrombosis and thrombolysis. In 1994 he extended his interests to clinical studies. Since founding the Coronary Clinical Trial Group within the Cardiac Unit in 1995, he has conducted numerous clinical studies. He also led Clinical Research Office of the Cardiology Division between 2003 and 2006. He is currently the Director of the Cardiology Laboratory for Integrative Physiology and Imaging (CLIPI).
For the last eleven years he has pioneered the application of intravascular Optical Coherence Tomography (OCT) to patients to better characterize vulnerable plaque and to understand the mechanisms of plaque rupture. Dr. Jang has been invited to lectures at numerous national and international meetings. His publications number more than 200.
ResearchDr. Jang's research focus has evolved from the pathogenesis and improved management of acute myocardial infarction to the prevention of acute coronary syndromes and sudden cardiac death. His research contributions include:
- Demonstrating the crucial role of platelets in the sensitivity of the thrombus to thrombolysis. His work provides the groundwork for future research of platelet inhibition therapy for acute coronary syndromes
- Demonstrating the role of thrombin in thrombosis and thrombolysis, and validating the thrombin hypothesis
- Organizing and conducting the international, multicenter clinical studies as a principal investigator to improve the treatment of patients with acute myocardial infarction
- Pioneering a new field of detection of vulnerable coronary plaques using optical coherence tomography (OCT)
Mass General researchers use optical coherence tomography to identify vulnerable coronary plaques
Mass General researchers are spearheading an international effort to study optical coherence tomography (OCT), an imaging technology that could help doctors identify the vulnerable coronary plaques that cause heart attacks. By creating extremely high-resolution images from within the artery, OCT can pinpoint the microscopic characteristics of a vulnerable plaque.
Optical coherence tomography: view a fly-through image of the coronary arteries
Researchers at Mass General are leading the first optical coherence tomography (OCT) registry, an international database of 3,000 patients who have received OCT. Optical coherence tomography is an intravascular imaging technique that may help physicians identify the vulnerable plaques that lead to heart attacks or sudden cardiac death.
The MGH leads international study to identify vulnerable coronary plaques
MGH Hotline 04.09.10 Optical coherence tomography (OCT) is an intravascular imaging technology that offers the promise of revealing the microscopic characteristics of a vulnerable coronary plaque.
Massachusetts General Hospital to create international registry for coronary optical coherence tomography
Mass General researchers are spearheading an international effort to study optical coherence tomography (OCT), an imaging technology that could help doctors identify the vulnerable coronary plaques that cause heart attacks.
55 Fruit Street
Boston, MA 02114
Phone: 617-726-9226
Fax: 617-726-7419
55 Fruit Street
Boston, MA 02114
Phone: 617-726-9226
Fax: 617-726-7419
Request a new patient appointment 
Call the Massachusetts General Hospital physician referral service at 800-711-4644.
Insurance plans - what you need to know
Mass General accepts most health insurance plans. Find out what you need to know before coming to Mass General.
Directions to Mass General
Driving to Mass General? Get driving directions or locate a parking lot on the hospital's main campus.
- © 2013 Massachusetts General Hospital
- 55 Fruit Street, Boston, MA 02114
- Maps & Directions
- 617-726-2000
- TDD: 617-724-8800
